Aarkstore - Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

1
Congestive Heart Failure (Heart Failure) -
Pipeline Review, H2 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/63081/congestive-heart-failure-heart-failure-pip
  eline-review

2
Congestive Heart Failure (Heart Failure) -
Pipeline Review, H2 2014
3
Summary

• Global Markets Directs, Congestive Heart
  Failure (Heart Failure) - Pipeline Review, H2
  2014, provides an overview of the Congestive
  Heart Failure (Heart Failure)s therapeutic
  pipeline.This report provides comprehensive
  information on the therapeutic development for
  Congestive Heart Failure (Heart Failure),
  complete with comparative analysis at various
  stages, therapeutics assessment by drug target,
  mechanism of action (MoA), route of
  administration (RoA) and molecule type, along
  with latest updates, and featured news and press
  releases. It also reviews key players involved in
  the therapeutic development for Congestive Heart
  Failure (Heart Failure) and special features on
  late-stage and discontinued projects.
• Global Markets Directs report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications. The report is built using data and
  information sourced from Global Markets Directs
  proprietary databases, Company/University
  websites, SEC filings, investor presentations and
  featured press releases from company/university
  sites and industry-specific third party sources,
  put together by Global Markets Directs team.

4
Summary

• Drug profiles/records featured in the report
  undergoes periodic updation following a stringent
  set of processes that ensures that all the
  profiles are updated with the latest set of
  information. Additionally, processes including
  live news deals tracking, browser based
  alert-box and clinical trials registries tracking
  ensure that the most recent developments are
  captured on a real time basis.The report
  enhances decision making capabilities and help to
  create effective counter strategies to gain
  competitive advantage. It strengthens RD
  pipelines by identifying new targets and MOAs to
  produce first-in-class and best-in-class
  products.Note Certain sections in the report
  may be removed or altered based on the
  availability and relevance of data for the
  indicated disease.

5
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Congestive Heart Failure
  (Heart Failure)- The report reviews key pipeline
  products under drug profile section which
  includes, product description, MoA and RD brief,
  licensing and collaboration details other
  developmental activities - The report reviews
  key players involved in the therapeutics
  development for Congestive Heart Failure (Heart
  Failure) and enlists all their major and minor
  projects- The report summarizes all the dormant
  and discontinued pipeline projects - A review of
  the Congestive Heart Failure (Heart Failure)
  products under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages- A detailed assessment of
  monotherapy and combination therapy pipeline
  projects- Coverage of the Congestive Heart
  Failure (Heart Failure) pipeline on the basis of
  target, MoA, route of administration and molecule
  type- Latest news and deals relating related to
  pipeline products

6
Reasons to buy

• - Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies- Identify
  emerging players with potentially strong product
  portfolio and create effective counter-strategies
  to gain competitive advantage- Develop strategic
  initiatives by understanding the focus areas of
  leading companies- Identify and understand
  important and diverse types of therapeutics under
  development for Congestive Heart Failure (Heart
  Failure)- Plan mergers and acquisitions
  effectively by identifying key players of the
  most promising pipeline- Devise corrective
  measures for pipeline projects by understanding
  Congestive Heart Failure (Heart Failure) pipeline
  depth and focus of Indication therapeutics-
  Develop and design in-licensing and out-licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and scope- Modify the
  therapeutic portfolio by identifying discontinued
  projects and understanding the factors that drove
  them from pipeline  

7
Table of Content
List of Tables 5List of Figures 7Introduction
8Global Markets Direct Report Coverage
8Congestive Heart Failure (Heart Failure)
Overview 9Therapeutics Development 10Pipeline
Products for Congestive Heart Failure (Heart
Failure) - Overview 10Pipeline Products for
Congestive Heart Failure (Heart Failure) -
Comparative Analysis 11Congestive Heart Failure
(Heart Failure) - Therapeutics under Development
by Companies 12Congestive Heart Failure (Heart
Failure) - Therapeutics under Investigation by
Universities/Institutes 17Congestive Heart
Failure (Heart Failure) - Pipeline Products
Glance 19Late Stage Products 19Clinical Stage
Products 20Early Stage Products 21
8
Table of Content
Congestive Heart Failure (Heart Failure) -
Products under Development by Companies
22Congestive Heart Failure (Heart Failure) -
Products under Investigation by
Universities/Institutes 26Congestive Heart
Failure (Heart Failure) - Companies Involved in
Therapeutics Development 28Acorda Therapeutics,
Inc. 28ARCA biopharma, Inc. 29Asklepios
BioPharmaceutical, Inc. 30Athersys, Inc.
31Bayer AG 32BEAT BioTherapeutics Corp.
33Bioheart, Inc. 34BioLineRx, Ltd.
35Bristol-Myers Squibb Company 36Cardio3
BioSciences SA 37Cardioxyl Pharmaceuticals, Inc.
38Celladon Corporation 39Cellmid Limited 40
9
List Of Tables

• Number of Products under Development for
  Congestive Heart Failure (Heart Failure), H2 2014
  16Number of Products under Development for
  Congestive Heart Failure (Heart Failure) -
  Comparative Analysis, H2 2014 17Number of
  Products under Development by Companies, H2 2014
  19Number of Products under Development by
  Companies, H2 2014 (Contd..1) 20Number of
  Products under Development by Companies, H2 2014
  (Contd..2) 21Number of Products under
  Development by Companies, H2 2014 (Contd..3)
  22Number of Products under Investigation by
  Universities/Institutes, H2 2014 24Comparative
  Analysis by Late Stage Development, H2 2014
  25Comparative Analysis by Clinical Stage
  Development, H2 2014 26Comparative Analysis by
  Early Stage Development, H2 2014 27Products
  under Development by Companies, H2 2014 28

10
List Of Tables

• Products under Development by Companies, H2 2014
  (Contd..3) 31Products under Investigation by
  Universities/Institutes, H2 2014 32Products
  under Investigation by Universities/Institutes,
  H2 2014 (Contd..1) 33Congestive Heart Failure
  (Heart Failure) - Pipeline by Acorda
  Therapeutics, Inc., H2 2014 34Congestive Heart
  Failure (Heart Failure) - Pipeline by ARCA
  biopharma, Inc., H2 2014 35Congestive Heart
  Failure (Heart Failure) - Pipeline by Asklepios
  BioPharmaceutical, Inc., H2 2014 36Congestive
  Heart Failure (Heart Failure) - Pipeline by
  Athersys, Inc., H2 2014 37Congestive Heart
  Failure (Heart Failure) - Pipeline by Bayer AG,
  H2 2014 38Congestive Heart Failure (Heart
  Failure) - Pipeline by BEAT BioTherapeutics
  Corp., H2 2014 39Congestive Heart Failure (Heart
  Failure) - Pipeline by Bioheart, Inc., H2 2014
  40Congestive Heart Failure (Heart Failure) -
  Pipeline by BioLineRx, Ltd., H2 2014 41

11
List of Figures

• Number of Products under Development for
  Congestive Heart Failure (Heart Failure), H2 2014
  16Number of Products under Development for
  Congestive Heart Failure (Heart Failure) -
  Comparative Analysis, H2 2014 17Number of
  Products under Development by Companies, H2 2014
  18Number of Products under Investigation by
  Universities/Institutes, H2 2014 23Comparative
  Analysis by Late Stage Development, H2 2014
  25Comparative Analysis by Clinical Stage
  Development, H2 2014 26Comparative Analysis by
  Early Stage Products, H2 2014 27Assessment by
  Monotherapy Products, H2 2014 73Number of
  Products by Top 10 Targets, H2 2014 75Number of
  Products by Stage and Top 10 Targets, H2 2014
  75Number of Products by Top 10 Mechanism of
  Actions, H2 2014 78Number of Products by Stage
  and Top 10 Mechanism of Actions, H2 2014
  78Number of Products by Top 10 Routes of
  Administration, H2 2014 80

12
Related Reports

• Global Neurosurgery Market 2015-2019
• BrainStorm Cell Therapeutics Inc. (BCLI) -
  Financial and Strategic SWOT Analysis Review
• Ampio Pharmaceuticals, Inc. (AMPE) - Financial
  and Strategic SWOT Analysis Review
• MiMedx Group, Inc (MDXG) - Financial and
  Strategic SWOT Analysis Review
• Threshold Pharmaceuticals, Inc. (THLD) -
  Financial and Strategic SWOT Analysis Review

13
Related Reports

• MEI Pharma, Inc. (MEIP) - Financial and Strategic
  SWOT Analysis Review
• Titan Pharmaceuticals, Inc. (TTNP) - Financial
  and Strategic SWOT Analysis Review
• RedHill Biopharma Ltd. (RDHL) - Financial and
  Strategic SWOT Analysis Review
• Pharmaceuticals Healthcare Market Research
  Reports

14

• Congestive Heart Failure (Heart Failure) -
  Pipeline Review, H2 2014
• Published Oct 2014 238 Pages
• Congestive Heart Failure (Heart Failure) -
  Pipeline Review, H2 2014 report features
  investigational drugs from across globe covering
  over 20 therapy areas and nearly 3,000
  indications.
  Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
15
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news